Title: Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease: Results From the CHARM Trial
Authors: Colombel, Jean-Frederic ×
Sandborn, William J
Rutgeerts, Paul
Kamm, Michael A
Yu, Andrew P
Wu, Eric Q
Pollack, Paul F
Lomax, Kathleen G
Chao, Jingdong
Mulani, Parvez M #
Issue Date: May-2009
Publisher: The Association
Series Title: American Journal of Gastroenterology vol:104 issue:5 pages:1170-1179
Abstract: OBJECTIVES: To compare outcomes of induction dosing followed by continuous adalimumab treatment with those of induction dosing with reinitiation of adalimumab (in the event of clinical deterioration) for patients with moderate-to-severe Crohn's disease (CD) who participated in the Crohn's Trial of the Fully Human Antibody Adalimumab for Remission Maintenance (CHARM).
ISSN: 0002-9270
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Translational Research in GastroIntestinal Disorders
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science